{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,4,29]],"date-time":"2026-04-29T22:30:02Z","timestamp":1777501802219,"version":"3.51.4"},"reference-count":66,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2019,10,1]],"date-time":"2019-10-01T00:00:00Z","timestamp":1569888000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2019,10,1]],"date-time":"2019-10-01T00:00:00Z","timestamp":1569888000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2020,7,4]],"date-time":"2020-07-04T00:00:00Z","timestamp":1593820800000},"content-version":"am","delay-in-days":277,"URL":"http:\/\/www.elsevier.com\/open-access\/userlicense\/1.0\/"}],"funder":[{"DOI":"10.13039\/501100004099","name":"Ligue Contre le Cancer","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100004099","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100011719","name":"Bone Cancer Research Trust","doi-asserted-by":"publisher","award":["144681"],"award-info":[{"award-number":["144681"]}],"id":[{"id":"10.13039\/100011719","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100002322","name":"Coordena\u00e7\u00e3o de Aperfei\u00e7oamento de Pessoal de N\u00edvel Superior","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100002322","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100006364","name":"Institut National Du Cancer","doi-asserted-by":"publisher","award":["INCa-6001"],"award-info":[{"award-number":["INCa-6001"]}],"id":[{"id":"10.13039\/501100006364","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Biochemical Pharmacology"],"published-print":{"date-parts":[[2019,10]]},"DOI":"10.1016\/j.bcp.2019.06.027","type":"journal-article","created":{"date-parts":[[2019,6,28]],"date-time":"2019-06-28T12:24:17Z","timestamp":1561724657000},"page":"133-148","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":11,"special_numbering":"C","title":["Genetically-achieved disturbances to the expression levels of TNFSF11 receptors modulate the effects of zoledronic acid on growing mouse skeletons"],"prefix":"10.1016","volume":"168","author":[{"given":"Jorge William","family":"Vargas-Franco","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Beatriz","family":"Castaneda","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-7403-9720","authenticated-orcid":false,"given":"Andrea","family":"Gama","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Christopher G.","family":"Mueller","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-7777-0669","authenticated-orcid":false,"given":"Dominique","family":"Heymann","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Fran\u00e7oise","family":"R\u00e9dini","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Fr\u00e9d\u00e9ric","family":"L\u00e9zot","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1016\/j.bcp.2019.06.027_b0005","doi-asserted-by":"crossref","first-page":"5696","DOI":"10.1002\/jcp.26465","article-title":"Paradoxical side effects of bisphosphonates on the skeleton: what do we know and what can we do?","volume":"233","author":"Vargas-Franco","year":"2018","journal-title":"J. Cell. Physiol."},{"key":"10.1016\/j.bcp.2019.06.027_b0010","doi-asserted-by":"crossref","first-page":"29","DOI":"10.1016\/j.bone.2016.10.004","article-title":"Timing of dental development in osteogenesis imperfecta patients with and without bisphosphonate treatment","volume":"94","author":"Vuorimies","year":"2017","journal-title":"Bone"},{"key":"10.1016\/j.bcp.2019.06.027_b0015","doi-asserted-by":"crossref","first-page":"321","DOI":"10.1111\/jop.12516","article-title":"Use of new targeted cancer therapies in children: effects on dental development and risk of jaw osteonecrosis: a review","volume":"46","author":"Hernandez","year":"2017","journal-title":"J. Oral Pathol. Med."},{"key":"10.1016\/j.bcp.2019.06.027_b0020","doi-asserted-by":"crossref","first-page":"146","DOI":"10.1016\/j.bone.2014.08.018","article-title":"Preclinical evidence of potential craniofacial adverse effect of zoledronic acid in pediatric patients with bone malignancies","volume":"68","author":"L\u00e9zot","year":"2014","journal-title":"Bone"},{"key":"10.1016\/j.bcp.2019.06.027_b0025","doi-asserted-by":"crossref","first-page":"502","DOI":"10.1007\/s00223-010-9366-z","article-title":"Administration of the bisphosphonate zoledronic acid during tooth development inhibits tooth eruption and formation and induces dental abnormalities in rats","volume":"86","author":"Hiraga","year":"2010","journal-title":"Calcif. Tissue Int."},{"key":"10.1016\/j.bcp.2019.06.027_b0030","doi-asserted-by":"crossref","first-page":"9","DOI":"10.1111\/adj.12140","article-title":"The use of bisphosphonates in children: review of the literature and guidelines for dental management","volume":"59","author":"Bhatt","year":"2014","journal-title":"Aust. Dent. J."},{"key":"10.1016\/j.bcp.2019.06.027_b0035","doi-asserted-by":"crossref","first-page":"1731","DOI":"10.1359\/JBMR.050604","article-title":"Transient disturbance in physeal morphology is associated with long-term effects of nitrogen-containing bisphosphonates in growing rabbits","volume":"20","author":"Smith","year":"2005","journal-title":"J. Bone Miner. Res."},{"key":"10.1016\/j.bcp.2019.06.027_b0040","doi-asserted-by":"crossref","first-page":"1235","DOI":"10.1359\/JBMR.050213","article-title":"Effects of intravenous pamidronate treatment in infants with osteogenesis imperfecta: clinical and histomorphometric outcome","volume":"20","author":"Munns","year":"2005","journal-title":"J. Bone Miner. Res."},{"key":"10.1016\/j.bcp.2019.06.027_b0045","doi-asserted-by":"crossref","first-page":"51","DOI":"10.1016\/j.bone.2014.12.011","article-title":"Skeletal consequences of RANKL-blocking antibody (IK22-5) injections during growth: mouse strain disparities and synergic effect with zoledronic acid","volume":"73","author":"L\u00e9zot","year":"2015","journal-title":"Bone"},{"key":"10.1016\/j.bcp.2019.06.027_b0050","doi-asserted-by":"crossref","first-page":"103","DOI":"10.1016\/j.bone.2011.01.003","article-title":"Safety of bisphosphonates","volume":"49","author":"Pazianas","year":"2011","journal-title":"Bone"},{"key":"10.1016\/j.bcp.2019.06.027_b0055","first-page":"30","article-title":"Pharmacokinetic profile of bisphosphonates in the treatment of metabolic bone disorders","volume":"4","author":"Sinigaglia","year":"2007","journal-title":"Clin. Cases Miner. Bone Metabol."},{"key":"10.1016\/j.bcp.2019.06.027_b0060","doi-asserted-by":"crossref","first-page":"56","DOI":"10.1016\/j.bone.2010.10.159","article-title":"Bisphosphonate effects on bone turnover, microdamage, and mechanical properties: What we think we know and what we know that we don\u2019t know","volume":"49","author":"Allen","year":"2011","journal-title":"Bone"},{"key":"10.1016\/j.bcp.2019.06.027_b0065","doi-asserted-by":"crossref","first-page":"151","DOI":"10.11005\/jbm.2015.22.4.151","article-title":"Medication related osteonecrosis of the jaw: 2015 position statement of the korean society for bone and mineral research and the Korean Association of Oral and Maxillofacial Surgeons","volume":"22","author":"Kim","year":"2015","journal-title":"J Bone Metab"},{"key":"10.1016\/j.bcp.2019.06.027_b0070","doi-asserted-by":"crossref","first-page":"1","DOI":"10.3389\/fimmu.2014.00511","article-title":"Biology of the RANKL-RANK-OPG system in immunity, bone, and beyond","volume":"5","author":"Walsh","year":"2014","journal-title":"Front. Immunol.."},{"key":"10.1016\/j.bcp.2019.06.027_b0075","doi-asserted-by":"crossref","first-page":"1","DOI":"10.2174\/0929867323666160907162546","article-title":"Osteoimmunology and beyond","volume":"23","author":"Ginaldi","year":"2016","journal-title":"Curr. Med. Chem."},{"key":"10.1016\/j.bcp.2019.06.027_b0080","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1371\/journal.pone.0080054","article-title":"Role of RANKL (TNFSF11)-dependent osteopetrosis in the dental phenotype of Msx2 null mutant mice","volume":"8","author":"Castaneda","year":"2013","journal-title":"PLoS ONE"},{"key":"10.1016\/j.bcp.2019.06.027_b0085","doi-asserted-by":"crossref","first-page":"1","DOI":"10.3390\/jcm7110426","article-title":"Maternal RANKL reduces the osteopetrotic phenotype of null mutant mouse pups","volume":"7","author":"Navet","year":"2018","journal-title":"J. Clin. Med."},{"key":"10.1016\/j.bcp.2019.06.027_b0090","doi-asserted-by":"crossref","first-page":"5050","DOI":"10.1210\/endo.142.12.8536","article-title":"Minireview: the opg\/rankl\/rank system","volume":"142","author":"Khosla","year":"2001","journal-title":"Endocrinology"},{"key":"10.1016\/j.bcp.2019.06.027_b0095","doi-asserted-by":"crossref","first-page":"534","DOI":"10.1159\/000371845","article-title":"The RANKL-RANK story","volume":"61","author":"Nagy","year":"2015","journal-title":"Gerontology"},{"key":"10.1016\/j.bcp.2019.06.027_b0100","doi-asserted-by":"crossref","first-page":"457","DOI":"10.1016\/j.cytogfr.2004.06.004","article-title":"The molecular triad OPG\/RANK\/RANKL: Involvement in the orchestration of pathophysiological bone remodeling","volume":"15","author":"Theoleyre","year":"2004","journal-title":"Cytokine Growth Factor Rev."},{"key":"10.1016\/j.bcp.2019.06.027_b0105","doi-asserted-by":"crossref","first-page":"3212","DOI":"10.3892\/mmr.2015.3152","article-title":"Receptor activator of nuclear factor-\u03baB ligand (RANKL)\/RANK\/osteoprotegerin system in bone and other tissues (Review)","volume":"11","author":"Liu","year":"2015","journal-title":"Mol. Med. Rep."},{"key":"10.1016\/j.bcp.2019.06.027_b0110","doi-asserted-by":"crossref","first-page":"139","DOI":"10.1016\/j.abb.2008.03.018","article-title":"Functions of RANKL\/RANK\/OPG in bone modeling and remodeling","volume":"473","author":"Boyce","year":"2008","journal-title":"Arch. Biochem. Biophys."},{"key":"10.1016\/j.bcp.2019.06.027_b0115","first-page":"542","article-title":"Serum levels of RANKL and OPG, and the RANKL\/OPG ratio in bisphosphonate-related osteonecrosis of the jaw: Are they useful biomarkers for the advanced stages of osteonecrosis?","volume":"22","author":"Bagan","year":"2017","journal-title":"Medicina Oral, Patologia Oral y Cirugia Bucal."},{"key":"10.1016\/j.bcp.2019.06.027_b0120","doi-asserted-by":"crossref","first-page":"45","DOI":"10.4081\/ejh.2015.2455","article-title":"RANK\/RANKL\/OPG signaling pathways in necrotic jaw bone from bisphosphonate-treated subjects","volume":"59","author":"Di Nisio","year":"2015","journal-title":"Eur. J. Histochem."},{"key":"10.1016\/j.bcp.2019.06.027_b0125","doi-asserted-by":"crossref","first-page":"45","DOI":"10.1038\/71667","article-title":"Mutations in TNFRSF11A, affecting the signal peptide of RANK, cause familial expansile osteolysis","volume":"24","author":"Hughes","year":"2000","journal-title":"Nat. Genet."},{"key":"10.1016\/j.bcp.2019.06.027_b0130","doi-asserted-by":"crossref","first-page":"175","DOI":"10.1056\/NEJMoa013096","article-title":"Osteoprotegerin deficiency and Juvenile Paget\u2019s disease","volume":"347","author":"Whyte","year":"2002","journal-title":"N. Engl. J. Med."},{"key":"10.1016\/j.bcp.2019.06.027_b0135","series-title":"Genetics of Bone Biology and Skeletal Disease, Second Edi","first-page":"453","article-title":"Mendelian Disorders of RANKL\/OPG\/RANK\/NF-\u03baB Signaling","author":"Whyte","year":"2016"},{"key":"10.1016\/j.bcp.2019.06.027_b0140","doi-asserted-by":"crossref","first-page":"1032","DOI":"10.4065\/83.9.1032","article-title":"Bisphosphonates: mechanism of action and role in clinical practice REVIEW","volume":"83","author":"Drake","year":"2008","journal-title":"Mayo Clin. Proc."},{"key":"10.1016\/j.bcp.2019.06.027_b0145","doi-asserted-by":"crossref","first-page":"5342","DOI":"10.1073\/pnas.1013054108","article-title":"Receptor activator of NF-\u03baB (RANK) stimulates the proliferation of epithelial cells of the epidermo-pilosebaceous unit","volume":"108","author":"Duheron","year":"2011","journal-title":"Proc. Natl. Acad. Sci. U.S.A."},{"key":"10.1016\/j.bcp.2019.06.027_b0150","doi-asserted-by":"crossref","first-page":"1","DOI":"10.3389\/fphys.2015.00417","article-title":"Postnatal ontogeny of the cranial base and craniofacial skeleton in male C57BL\/6J mice: a reference standard for quantitative analysis","volume":"6","author":"Vora","year":"2016","journal-title":"Front. Physiol."},{"key":"10.1016\/j.bcp.2019.06.027_b0155","doi-asserted-by":"crossref","first-page":"92","DOI":"10.1111\/ocr.12035","article-title":"Cephalometric assessment of craniofacial dysmorphologies in relation with Msx2 mutations in mouse","volume":"17","author":"Simon","year":"2014","journal-title":"Orthod. Craniofac. Res."},{"key":"10.1016\/j.bcp.2019.06.027_b0160","series-title":"Basic and Applied Bone Biology","first-page":"75","article-title":"Bone modeling and remodeling","author":"Allen","year":"2013"},{"key":"10.1016\/j.bcp.2019.06.027_b0165","doi-asserted-by":"crossref","first-page":"809","DOI":"10.1016\/j.beem.2014.09.003","article-title":"Efficacy and safety of currently marketed anti-osteoporosis medications","volume":"28","author":"Reginster","year":"2014","journal-title":"Best Pract. Res. Clin. Endocrinol. Metabol."},{"key":"10.1016\/j.bcp.2019.06.027_b0170","doi-asserted-by":"crossref","first-page":"74","DOI":"10.1002\/jcp.22305","article-title":"Bone resorption control of tooth eruption and root morphogenesis: involvement of the receptor activator of NF-kB (RANK)","volume":"226","author":"Castaneda","year":"2011","journal-title":"J. Cell. Physiol."},{"key":"10.1016\/j.bcp.2019.06.027_b0175","doi-asserted-by":"crossref","first-page":"1","DOI":"10.3389\/fphys.2015.00319","article-title":"Bone resorption: an actor of dental and periodontal development?","volume":"6","author":"Gama","year":"2015","journal-title":"Front. Physiol."},{"key":"10.1016\/j.bcp.2019.06.027_b0180","doi-asserted-by":"crossref","first-page":"238","DOI":"10.1159\/000324787","article-title":"Osteoclasts in the dental microenvironment: a delicate balance controls dental histogenesis","volume":"194","author":"Berdal","year":"2011","journal-title":"Cells Tissues Organs."},{"key":"10.1016\/j.bcp.2019.06.027_b0185","doi-asserted-by":"crossref","first-page":"288","DOI":"10.1016\/j.archoralbio.2010.02.007","article-title":"OPG knockout mouse teeth display reduced alveolar bone mass and hypermineralization in enamel and dentin","volume":"55","author":"Sheng","year":"2010","journal-title":"Arch. Oral Biol."},{"key":"10.1016\/j.bcp.2019.06.027_b0190","doi-asserted-by":"crossref","first-page":"773","DOI":"10.1210\/en.2012-1928","article-title":"Osteoprotegerin-deficient male mice as a model for severe alveolar bone loss: comparison with RANKL-overexpressing transgenic male mice","volume":"154","author":"Koide","year":"2013","journal-title":"Endocrinology"},{"key":"10.1016\/j.bcp.2019.06.027_b0195","doi-asserted-by":"crossref","first-page":"1516","DOI":"10.1016\/j.joen.2016.07.008","article-title":"Osteoprotegerin-knockout mice developed early onset root resorption","volume":"42","author":"Liu","year":"2016","journal-title":"J. Endodontics."},{"key":"10.1016\/j.bcp.2019.06.027_b0200","doi-asserted-by":"crossref","first-page":"329","DOI":"10.1007\/s10735-018-9771-6","article-title":"Osteoprotegerin deficiency causes morphological and quantitative damage in epithelial rests of Malassez","volume":"49","author":"Wang","year":"2018","journal-title":"J. Mol. Histol."},{"key":"10.1016\/j.bcp.2019.06.027_b0205","doi-asserted-by":"crossref","first-page":"1","DOI":"10.3389\/fphys.2017.00338","article-title":"RANK\/RANKL\/OPG signalization implication in periodontitis: new evidence from a RANK transgenic mouse model","volume":"8","author":"Sojod","year":"2017","journal-title":"Front. Physiol."},{"key":"10.1016\/j.bcp.2019.06.027_b0210","doi-asserted-by":"crossref","first-page":"911","DOI":"10.1002\/jbmr.2094","article-title":"Panostotic expansile bone disease with massive jaw tumor formation and a novel mutation in the signal peptide of RANK","volume":"29","author":"Schafer","year":"2014","journal-title":"J. Bone Miner. Res."},{"key":"10.1016\/j.bcp.2019.06.027_b0215","doi-asserted-by":"crossref","first-page":"1381","DOI":"10.1359\/jbmr.2003.18.8.1381","article-title":"Phenotypic characterization of early onset paget\u2019s disease of bone caused by a 27-bp duplication in the TNFRSF11A gene","volume":"18","author":"Nakatsuka","year":"2003","journal-title":"J. Bone Miner. Res."},{"key":"10.1016\/j.bcp.2019.06.027_b0220","doi-asserted-by":"crossref","first-page":"272","DOI":"10.1007\/s00223-008-9177-7","article-title":"Clinical and biochemical response of TNFRSF11A-mediated early-onset familial paget disease to bisphosphonate therapy","volume":"83","author":"Riches","year":"2008","journal-title":"Calcif. Tissue Int."},{"key":"10.1016\/j.bcp.2019.06.027_b0225","doi-asserted-by":"crossref","first-page":"1204","DOI":"10.1038\/aps.2009.90","article-title":"Early onset Paget\u2019s disease of bone caused by a novel mutation (78dup27) of the TNFRSF11A gene in a Chinese family","volume":"30","author":"Ke","year":"2009","journal-title":"Acta Pharmacol. Sin."},{"key":"10.1016\/j.bcp.2019.06.027_b0230","doi-asserted-by":"crossref","first-page":"241","DOI":"10.1177\/154405910408300311","article-title":"Opg, Rank, and Rankl in tooth development: co-ordination of odontogenesis and osteogenesis","volume":"83","author":"Ohazama","year":"2004","journal-title":"J. Dent. Res."},{"key":"10.1016\/j.bcp.2019.06.027_b0235","doi-asserted-by":"crossref","first-page":"1272","DOI":"10.1002\/jbmr.325","article-title":"Osteoprotegerin deficiency attenuates strontium-mediated inhibition of osteoclastogenesis and bone resorption","volume":"26","author":"Peng","year":"2011","journal-title":"J. Bone Miner. Res."},{"key":"10.1016\/j.bcp.2019.06.027_b0240","doi-asserted-by":"crossref","first-page":"539","DOI":"10.1038\/nm.4076","article-title":"LGR4 is a receptor for RANKL and negatively regulates osteoclast differentiation and bone resorption","volume":"22","author":"Luo","year":"2016","journal-title":"Nat. Med."},{"key":"10.1016\/j.bcp.2019.06.027_b0245","doi-asserted-by":"crossref","first-page":"2133","DOI":"10.1016\/j.bbrc.2017.12.091","article-title":"Inhibitory activity of linarin on osteoclastogenesis through receptor activator of nuclear factor \u03baB ligand-induced NF-\u03baB pathway","volume":"495","author":"Wang","year":"2018","journal-title":"Biochem. Biophys. Res. Commun."},{"key":"10.1016\/j.bcp.2019.06.027_b0250","first-page":"1026","article-title":"MicroRNA-137 dysregulation predisposes to osteoporotic fracture by impeding ALP activity and expression via suppression of leucine-rich repeat-containing G-protein-coupled receptor 4 expression","volume":"42","author":"Liu","year":"2018","journal-title":"Int. J. Mol. Med."},{"key":"10.1016\/j.bcp.2019.06.027_b0255","doi-asserted-by":"crossref","first-page":"30","DOI":"10.1016\/j.lfs.2018.03.038","article-title":"Continuous application of compressive force induces fusion of osteoclast-like RAW264.7 cells via upregulation of RANK and downregulation of LGR4","volume":"201","author":"Matsuike","year":"2018","journal-title":"Life Sci."},{"key":"10.1016\/j.bcp.2019.06.027_b0260","doi-asserted-by":"crossref","first-page":"5","DOI":"10.3390\/ijms18030564","article-title":"Evidence of the role of R-spondin 1 and its receptor Lgr4 in the transmission of mechanical stimuli to biological signals for bone formation","volume":"18","author":"Shi","year":"2017","journal-title":"Int. J. Mol. Sci."},{"key":"10.1016\/j.bcp.2019.06.027_b0265","doi-asserted-by":"crossref","first-page":"93","DOI":"10.1016\/j.pbiomolbio.2016.05.012","article-title":"The role of R-spondins and their receptors in bone metabolism","volume":"122","author":"Shi","year":"2016","journal-title":"Prog. Biophys. Mol. Biol."},{"key":"10.1016\/j.bcp.2019.06.027_b0270","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/j.gene.2017.01.028","article-title":"MicroRNA-34c promotes osteoclast differentiation through targeting LGR4","volume":"610","author":"Cong","year":"2017","journal-title":"Gene"},{"key":"10.1016\/j.bcp.2019.06.027_b0275","doi-asserted-by":"crossref","first-page":"1761","DOI":"10.1002\/jcp.25684","article-title":"Lgr4 expression in osteoblastic cells is suppressed by hydrogen peroxide treatment","volume":"232","author":"Pawaputanon Na Mahasarakham","year":"2017","journal-title":"J. Cell. Physiol."},{"key":"10.1016\/j.bcp.2019.06.027_b0280","doi-asserted-by":"crossref","first-page":"887","DOI":"10.1002\/jcp.25180","article-title":"BMP-2 enhances lgr4 gene expression in osteoblastic cells","volume":"231","author":"Pawaputanon Na Mahasarakham","year":"2016","journal-title":"J. Cell. Physiol."},{"key":"10.1016\/j.bcp.2019.06.027_b0285","doi-asserted-by":"crossref","first-page":"989","DOI":"10.1016\/j.cellsig.2016.04.010","article-title":"LGR4 acts as a key receptor for R-spondin 2 to promote osteogenesis through Wnt signaling pathway","volume":"28","author":"Zhu","year":"2016","journal-title":"Cell. Signal."},{"key":"10.1016\/j.bcp.2019.06.027_b0290","doi-asserted-by":"crossref","first-page":"1245","DOI":"10.4049\/jimmunol.1101513","article-title":"RANKL induces organized lymph node growth by stromal cell proliferation","volume":"188","author":"Hess","year":"2012","journal-title":"J. Immunol."},{"key":"10.1016\/j.bcp.2019.06.027_b0295","doi-asserted-by":"crossref","first-page":"325","DOI":"10.1007\/s00418-018-1636-2","article-title":"Recent advances in osteoclast biology","volume":"149","author":"Ono","year":"2018","journal-title":"Histochem. Cell Biol."},{"key":"10.1016\/j.bcp.2019.06.027_b0300","doi-asserted-by":"crossref","first-page":"814","DOI":"10.1002\/jbmr.3052","article-title":"Bisphosphonate withdrawal: effects on bone formation and bone resorption in maturing male mice","volume":"32","author":"Ko","year":"2017","journal-title":"J. Bone Miner. Res."},{"key":"10.1016\/j.bcp.2019.06.027_b0305","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1186\/1472-6890-14-31","article-title":"Giant osteoclasts in patients under bisphosphonates","volume":"14","author":"Mac-Way","year":"2014","journal-title":"BMC Clin. Pathol."},{"key":"10.1016\/j.bcp.2019.06.027_b0310","doi-asserted-by":"crossref","first-page":"17","DOI":"10.1210\/en.2011-1439","article-title":"Increased numbers of nonattached osteoclasts after long-term zoledronic acid therapy in mice","volume":"153","author":"Kuroshima","year":"2012","journal-title":"Endocrinology"},{"key":"10.1016\/j.bcp.2019.06.027_b0315","doi-asserted-by":"crossref","first-page":"53","DOI":"10.1056\/NEJMoa0802633","article-title":"Giant Osteoclast Formation and Long-Term Oral Bisphosphonate Therapy","volume":"360","author":"Weinstein","year":"2009","journal-title":"New Engl. J. Med."},{"key":"10.1016\/j.bcp.2019.06.027_b0320","doi-asserted-by":"crossref","first-page":"341","DOI":"10.1038\/nrrheum.2009.87","article-title":"Giant osteoclasts after long-term bisphosphonate therapy: diagnostic challenges","volume":"5","author":"Jain","year":"2009","journal-title":"Nat. Rev. Rheumatol."},{"key":"10.1016\/j.bcp.2019.06.027_b0325","doi-asserted-by":"crossref","first-page":"1387","DOI":"10.1016\/j.jcms.2016.07.015","article-title":"Severe compromise of preosteoblasts in a surgical mouse model of bisphosphonate-associated osteonecrosis of the jaw","volume":"44","author":"C\u00f3rdova","year":"2016","journal-title":"J. Cranio-Maxillofacial Surg."},{"key":"10.1016\/j.bcp.2019.06.027_b0330","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1155\/2012\/526236","article-title":"Influence of bisphosphonate treatment on medullary macrophages and osteoclasts: an experimental study","volume":"2012","author":"Escudero","year":"2012","journal-title":"Bone Marrow Res."}],"container-title":["Biochemical Pharmacology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0006295219302552?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0006295219302552?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,4,28]],"date-time":"2026-04-28T15:16:54Z","timestamp":1777389414000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0006295219302552"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2019,10]]},"references-count":66,"alternative-id":["S0006295219302552"],"URL":"https:\/\/doi.org\/10.1016\/j.bcp.2019.06.027","relation":{},"ISSN":["0006-2952"],"issn-type":[{"value":"0006-2952","type":"print"}],"subject":[],"published":{"date-parts":[[2019,10]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Genetically-achieved disturbances to the expression levels of TNFSF11 receptors modulate the effects of zoledronic acid on growing mouse skeletons","name":"articletitle","label":"Article Title"},{"value":"Biochemical Pharmacology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.bcp.2019.06.027","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2019 Elsevier Inc. All rights reserved.","name":"copyright","label":"Copyright"}]}}